Hemas Hospital Wattala reaffirmed its commitment to collaboration and medical innovation through its sponsorship of the Annual Academic Sessions of the Sri Lanka Society of Gastroenterology (SLSG) 2025.

Recently, Hemas Hospital Wattala introduced the most advanced Fibroscan machine in the country, positioning the hospital at the forefront of liver care. During the SLSG event, live demonstrations showcased how this next-generation technology enabled clinicians to accurately assess liver stiffness and fat content in minutes, providing a painless, reliable, and efficient alternative to traditional biopsies. This innovation supported early detection, better monitoring, and more personalised treatment plans for patients with liver disease.

As the leading centre for liver care in Sri Lanka, Hemas Hospital Wattala Liver Centre has set benchmarks in early diagnosis, prevention, and management of liver-related diseases. Its multidisciplinary team of hepatologists, gastroenterologists, interventional radiologists, and surgeons deliver integrated, patient-centred care, supported by advanced diagnostics and specialised treatments such as endoscopic procedures, liver fibrosis assessment, and chronic liver disease management. The centre also provides education and awareness initiatives to empower patients and the wider community on liver health. Expanding its services, the centre introduced the private sector’s first pediatric liver unit, offering child-friendly, family-sensitive care with dedicated Fibroscan diagnostics and multidisciplinary planning, underscoring Hemas Hospitals’ commitment to its clinical excellence.

Mr. Prabhan Gunawardena, Director General Manager of Hemas Hospital Wattala, stated, “Participation of Hemas Hospital Wattala at this year’s SLSG Annual Academic Sessions reflected our ongoing commitment to professional collaboration and medical innovation. By engaging closely with Sri Lanka’s leading specialists, we contribute towards research, education, and the overall standard of gastroenterological care in the country. We will continue to work on improving further, strengthening our contributions to the healthcare sector”.

Through its support of the SLSG and its continuous investment in cutting-edge liver care technology, Hemas Hospital Wattala reaffirmed its position as a national leader in liver health. It pioneered advancements that promised better outcomes and a brighter future for patients across the country.

Photo Caption: Hemas Hospital Wattala showcased its advanced Fibroscan technology at SLSG 2025, reaffirming its leadership in liver diagnostics and care.